Track recorded fund announcements, transactions, leadership appointments and strategic developments from DataBane's published research.
BC Partners Lending Corporation completed its merger with Alternative Credit Income Fund, with BCPL surviving. Combined net asset value exceeded $223 million as of September 26, 2026. That vehicle NAV is not BC Partners' consolidated group AUM.
ContextLogic agreed to acquire gChem at $850 million enterprise value. BC Partners and Abrams Capital were among the equity rights-offering backstop investors. The $850 million is gChem enterprise value, not BC Partners' commitment.
BC Partners agreed to acquire co-control of Switzerland-based InfoRLife from its founder and ACS Dobfar shareholders. It is described as BC Partners Fund XII's second investment. Financial terms were undisclosed and closing was still pending in October 2026.
Fortidia confirmed the completion of BC Partners' majority acquisition on March 6, 2026, following a December 16, 2025 agreement. The Fiorelli family and Oaktree-managed funds were sellers; CEO Paolo Fiorelli retains a meaningful stake. Purchase price and exact ownership were not disclosed.
BC Partners and Bpifrance completed acquisition of French pharmaceutical company Biogaran from Servier. Bpifrance is a significant minority shareholder. No financial consideration was reported.
ContextLogic announced its proposed $907.5 million enterprise-value acquisition of US Salt, with a rights offering backstopped by Abrams Capital and BC Partners. Enterprise value is not a BC Partners investment allocation.
